A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy
Kidney International · 2024
DOI: 10.1016/j.kint.2024.01.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von Cătălin D Voinescu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Genetics and Genomics, Department of Renal Medicine, UCL Division of Medicine, University College London, London, UK. Hauptthemen laut MEDLINE: Neanderthals, Glomerulonephritis, Membranous. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saint Peter's Trust for Kidney Bladder and Prostate Research, Kidney Research UK.
Abstract (Originalsprache)
Class 2 HLA and PLA2R1 alleles are exceptionally strong genetic risk factors for membranous nephropathy (MN), leading, through an unknown mechanism, to a targeted autoimmune response. Introgressed archaic haplotypes (introduced from an archaic human genome into the modern human genome) might influence phenotypes through gene dysregulation. Here, we investigated the genomic region surrounding the PLA2R1 gene. We reconstructed the phylogeny of Neanderthal and modern haplotypes in this region and calculated the probability of the observed clustering being the result of introgression or common descent. We imputed variants for the participants in our previous genome-wide association study and we compared the distribution of Neanderthal variants between MN cases and controls. The region associated with the lead MN risk locus in the PLA2R1 gene was confirmed and showed that, within a 507 kb region enriched in introgressed sequence, a stringently defined 105 kb haplotype, intersecting the coding regions for PLA2R1 and ITGB6, is inherited from Neanderthals. Thus, introgressed Neanderthal haplotypes overlapping PLA2R1 are differentially represented in MN cases and controls, with enrichment In controls suggesting a protective effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Genetics and Genomics, Department of Renal Medicine, UCL Division of Medicine, University College London, London, UK.
- Department of Human and Medical Genetics, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
- Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA;…
- Grupo de Investigación en Psiquiatría, Departamento de Psiquiatría, Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
- Centre for Genetics and Genomics, Department of Renal Medicine, UCL Division of Medicine, University College London, London, UK. Electronic address: h.stanescu@ucl.ac.uk.
Förderung
- Saint Peter's Trust for Kidney Bladder and Prostate Research
- Kidney Research UK
Zitieren
APA
Voinescu, C. D., Mozere, M., Genovese, G., Downie, M. L., Gupta, S., Gale, D. P., Bockenhauer, D., Kleta, R., Arcos-Burgos, M., & Stanescu, H. C. (2024). A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy. Kidney International. https://doi.org/10.1016/j.kint.2024.01.017
Vancouver
Voinescu CD, Mozere M, Genovese G, Downie ML, Gupta S, Gale DP, et al. A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy. Kidney International. 2024. doi:10.1016/j.kint.2024.01.017
BibTeX
@article{Voinescu2024,
author = {Voinescu, Cătălin D and Mozere, Monika and Genovese, Giulio and Downie, Mallory L and Gupta, Sanjana and Gale, Daniel P and Bockenhauer, Detlef and Kleta, Robert and Arcos-Burgos, Mauricio and Stanescu, Horia C},
title = {A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy},
journal = {Kidney International},
year = {2024},
doi = {10.1016/j.kint.2024.01.017}
}
EUVIMED